Michael Shi

Michael Shi

Company: Transcenta

Job title: Chief Medical Officer


Clinical Update on TST005 11:00 am

Updates on the current clinical trials for this bi-functional anti-PD-L1 and TGF-β trap fusion protein Exploring the findings and improved therapeutic window Future directions to ensure continued successRead more

day: Track B - Day 1 AM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.